Zhu DX - Search Results

1

Impact of early tumor shrinkage on clinical outcome in wild-type-KRAS colorectal liver metastases treated with cetuximab.

Ye LC, Wei Y, Zhu DX, Chen T, Xu J. Ye LC, et al. Among authors: zhu dx. J Gastroenterol Hepatol. 2015 Apr;30(4):674-9. doi: 10.1111/jgh.12847. J Gastroenterol Hepatol. 2015. PMID: 25387601 Clinical Trial.

2

[Application of the protocol of enhanced recovery after surgery in colorectal surgery].

Xu JM, Zhong YS, Zhu DX, Ren L, Wei Y, Xue ZG, Jin L, Niu WX, Qin XY, Wu ZG. Xu JM, et al. Among authors: zhu dx. Zhonghua Wei Chang Wai Ke Za Zhi. 2007 May;10(3):238-44. Zhonghua Wei Chang Wai Ke Za Zhi. 2007. PMID: 17520382 Clinical Trial. Chinese.

3

[Therapeutic effects of hepatic resection in liver metastasis of colorectal cancer].

Xu JM, Zhong YS, Fan J, Zhou J, Qin LX, Niu WX, Wei Y, Ren L, Lai YH, Zhu DX, Qin XY, Wu ZH. Xu JM, et al. Among authors: zhu dx. Zhonghua Wai Ke Za Zhi. 2007 Apr 1;45(7):452-4. Zhonghua Wai Ke Za Zhi. 2007. PMID: 17686299 Chinese.

4

[Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].

Lai YH, Xu JM, Yu XZ, Zhong YS, Wei Y, Ren L, Zhu DX, Liu YK, Niu WX, Qin XY. Lai YH, et al. Among authors: zhu dx. Zhonghua Wai Ke Za Zhi. 2008 Jul 1;46(13):995-7. Zhonghua Wai Ke Za Zhi. 2008. PMID: 19035201 Chinese.

5

[Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].

Shi YJ, Zhao Y, Xu JM, Lai YH, Yu XZ, Zhong YS, Wei Y, Ren L, Zhu DX, Liu YK, Niu WX, Qin XY. Shi YJ, et al. Among authors: zhu dx. Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):910-3. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173991 Chinese.

6

Enhanced Recovery After Surgery (ERAS) program attenuates stress and accelerates recovery in patients after radical resection for colorectal cancer: a prospective randomized controlled trial.

Ren L, Zhu D, Wei Y, Pan X, Liang L, Xu J, Zhong Y, Xue Z, Jin L, Zhan S, Niu W, Qin X, Wu Z, Wu Z. Ren L, et al. World J Surg. 2012 Feb;36(2):407-14. doi: 10.1007/s00268-011-1348-4. World J Surg. 2012. PMID: 22102090 Clinical Trial.

7

[Application of enhanced recovery program after surgery(ERAS) in patients undergoing radical resection for colorectal cancer].

Zhu DX, Wei Y, Ren L, Pan XO, Liang L, Zhai SY, Xu JM, Zhong YS, Xue ZG, Jin L, Niu WX, Qin XY, Wu ZH, Wu ZG. Zhu DX, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Jun;15(6):555-60. Zhonghua Wei Chang Wai Ke Za Zhi. 2012. PMID: 22736121 Clinical Trial. Chinese.

8

Serum proteomic profiling for the early diagnosis of colorectal cancer.

Zhu D, Wang J, Ren L, Li Y, Xu B, Wei Y, Zhong Y, Yu X, Zhai S, Xu J, Qin X. Zhu D, et al. J Cell Biochem. 2013 Feb;114(2):448-55. doi: 10.1002/jcb.24384. J Cell Biochem. 2013. PMID: 22961748

9

[Study on relationship of the K-ras mutation with the occurrence of colorectal liver metastasis and survival outcomes].

Liang L, Wei Y, Zhong YS, Ren L, Zhu DX, Pan XO, Xu JM. Liang L, et al. Among authors: zhu dx. Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Nov;15(11):1156-61. Zhonghua Wei Chang Wai Ke Za Zhi. 2012. PMID: 23172529 Chinese.

10

Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases.

Ye LC, Liu TS, Ren L, Wei Y, Zhu DX, Zai SY, Ye QH, Yu Y, Xu B, Qin XY, Xu J. Ye LC, et al. Among authors: zhu dx. J Clin Oncol. 2013 Jun 1;31(16):1931-8. doi: 10.1200/JCO.2012.44.8308. Epub 2013 Apr 8. J Clin Oncol. 2013. PMID: 23569301 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters